BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19015354)

  • 1. In vitro and in vivo properties of ellagic acid in malaria treatment.
    Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.
    de Pilla Varotti F; Botelho AC; Andrade AA; de Paula RC; Fagundes EM; Valverde A; Mayer LM; Mendonça JS; de Souza MV; Boechat N; Krettli AU
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3868-74. PubMed ID: 18710907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
    Wilson DW; Langer C; Goodman CD; McFadden GI; Beeson JG
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1455-67. PubMed ID: 23318799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
    Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C
    Malar J; 2009 Jan; 8():10. PubMed ID: 19138388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
    Cheruiyot AC; Auschwitz JM; Lee PJ; Yeda RA; Okello CO; Leed SE; Talwar M; Murthy T; Gaona HW; Hickman MR; Akala HM; Kamau E; Johnson JD
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2417-24. PubMed ID: 26856829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
    Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
    Tougan T; Toya Y; Uchihashi K; Horii T
    Malar J; 2019 Jan; 18(1):8. PubMed ID: 30642330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
    Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
    Suputtamongkol Y; Chindarat S; Silpasakorn S; Chaikachonpatd S; Lim K; Chanthapakajee K; Kaewkaukul N; Thamlikitkul V
    Am J Trop Med Hyg; 2003 May; 68(5):620-3. PubMed ID: 12812357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
    Sato A; Hiramoto A; Morita M; Matsumoto M; Komich Y; Nakase Y; Tanigawa N; Hiraoka O; Hiramoto K; Hayatsu H; Higaki K; Kawai S; Masuyama A; Nojima M; Wataya Y; Kim HS
    Parasitol Int; 2011 Sep; 60(3):270-3. PubMed ID: 21501696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum.
    Garavito G; Bertani S; Rincon J; Maurel S; Monje MC; Landau I; Valentin A; Deharo E
    Parasite; 2007 Jun; 14(2):135-40. PubMed ID: 17645185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen.
    Al-Shamahy H; Al-Harazy AH; Harmal NS; Al-Kabsi AM
    Ann Saudi Med; 2007; 27(6):432-6. PubMed ID: 18059124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of glutathione in the in vitro antiplasmodial mechanism of action of ellagic acid.
    Njomnang Soh P; Witkowski B; Gales A; Huyghe E; Berry A; Pipy B; Benoit-Vical F
    PLoS One; 2012; 7(9):e45906. PubMed ID: 23029306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.